Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis.

@article{Aikawa2013EffectiveSA,
  title={Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis.},
  author={N{\'a}dia Emi Aikawa and L{\'u}cia Maria de Arruda Campos and Cl{\'a}udia Goldenstein-Schainberg and Carla Gonçalves Schain Saad and Ana Cristina de Medeiros Ribeiro and Cleonice Bueno and A R Precioso and Maria do Carmo Sampaio Tavares Timenetsky and Clovis A Silva and Elo{\'i}sa Silva Dutra de Oliveira Bonf{\'a}},
  journal={Scandinavian journal of rheumatology},
  year={2013},
  volume={42 1},
  pages={34-40}
}
OBJECTIVES To assess the vaccine response in juvenile idiopathic arthritis (JIA) as an extension of previous observation of immunogenicity and safety of a non-adjuvanted influenza A H1N1/2009 vaccine in a large population of juvenile rheumatic diseases. Moreover, to assess the possible influence of demographic data, disease subtypes, disease activity, and treatment on immunogenicity and the potential deleterious effect of the vaccine in the disease itself, particularly in the number of… CONTINUE READING